Collectively, our findings demonstrated that in tumor cell glutamine metabolism, the GLUL-mediated FGF17/FGFR4/MEK5/ERK5 signaling axis sustains redox homeostasis in the tumor microenvironment via activation of NRF2-dependent antioxidant programs. This evidence concerns the gene GLUL and neoplasm.